Genentech, Inc. at Citigroup Healthcare Conference Transcript - Transcript - 2008/05/22 - Thomson StreetEvents

The Premium Business Information Source™

Thomson StreetEvents

Title:	Genentech, Inc. at Citigroup Healthcare Conference Transcript
Price:	$54.00
Publication Date:	May 22, 2008
Source:	Thomson StreetEvents
Company:	Genentech, Inc.
Report Type:	Transcript
Abstract:	Final Transcript of DNA presentation, 22-May-08 8:00am ET
Brief Excerpt:	...and the -- I forgot the color -- the orange color is our tissue growth and repair; and then finally, our pinkish line represents our neuroscience area, a brand-new area we just announced at our March analyst meeting. And we already have our first antibody in there with the IND filing, preparing for Phase I -- it's our anti-A beta molecule being examined in Alzheimer's disease. This is our late-stage development pipeline. Taking a look at that, as I said, John is going to focus on our Avastin products. But we also have some interesting products where we're anticipating data sometime in the near future in this. The first one being Lucentis. If you look at the Lucentis, that's the orange-ish line. As you know, Lucentis has been approved for the treatment of AMD, but we're also evaluating the use of Lucentis in the treatment of diabetic macular edema, which is the second leading cause of visual disability in adults over ##, as well as retinal vein occlusion, the third leading cause of blindness...
Word Count:	4381
Length:	7 Pages
Ticker:	DNA
Time:	8:00am ET
Related Report(s):	Genentech, Inc. at Lazard Capital Markets Healthcare Conference Transcript: $54.00 Final Transcript of DNA presentation, 18-Nov-08 10:55am ET Genentech, Inc. Q3 2008 Earnings Conference Call Summary: $54.00 Edited Brief of DNA earnings conference call or presentation, 14-Oct-08 4:45pm ET Genentech, Inc. Q3 2008 Earnings Conference Call Transcript: $54.00 Final Transcript of DNA earnings conference call or presentation, 14-Oct-08 4:45pm ET Genentech, Inc. at UBS Global Life Sciences Conference Transcript: $54.00 Final Transcript of DNA presentation, 24-Sep-08 9:30am ET Genentech, Inc. at Morgan Stanley Global Healthcare Unplugged Conference Transcript: $54.00 Final Transcript of DNA presentation, 9-Sep-08 8:35am ET Genentech, Inc. at Thomas Weisel Partners Healthcare Conference Transcript: $54.00 Final Transcript of DNA presentation, 4-Sep-08 9:45am ET Genentech, Inc. Q2 2008 Earnings Conference Call Summary: $54.00 Edited Brief of DNA earnings conference call or presentation, 14-Jul-08 4:45pm ET Genentech, Inc. Q2 2008 Earnings Conference Call Transcript: $54.00 Final Transcript of DNA earnings conference call or presentation, 14-Jul-08 4:45pm ET
Format:	Adobe Acrobat
Free Sample:	Click Here to Download

Enter the keyword(s) which you would like to search for within this document and click "Search"



Price: $54.00

Looking For Something Else?

Search the Alacra Store

Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool. <br/>Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

about us

public company index

private company index

Copyright © 2008 Alacra, Inc., 100 Broadway, Suite 1100, New York, NY 10005. All rights reserved.
Reproduction in whole or in part in any form or medium without express written permission is prohibited.